Skip to content
Products & Services · Total revenues

Other — Total revenues

Alnylam Pharmaceuticals Other — Total revenues decreased by 25.1% to $1.24M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.6%, from $1.22M to $1.24M. Over 2 years (FY 2023 to FY 2025), Other — Total revenues shows an upward trend with a 23.9% CAGR.

Analysis

StatementSegment
First reportedQ1 2023
Last reportedQ1 2026Apr 30, 2026
Rolls up toTotal Revenue
Metric ID: alny_segment_other_total_revenues

Historical Data

13 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$957K$957K$957K$957K$2.53M$3.71M$1.41M$1.09M$1.22M$1.58M$1.44M$1.65M$1.24M
QoQ Change+0.0%+0.0%+0.0%+164.3%+46.7%-62.1%-22.4%+11.6%+29.7%-8.8%+14.6%-25.1%
YoY Change+164.3%+287.6%+46.8%+13.9%-51.9%-57.5%+2.3%+51.2%+1.6%
Range$957K$3.71M
CAGR+8.9%
Avg YoY Growth+50.9%
Median YoY Growth+13.9%

Frequently Asked Questions

What is Alnylam Pharmaceuticals's other — total revenues?
Alnylam Pharmaceuticals (ALNY) reported other — total revenues of $1.24M in Q1 2026.
How has Alnylam Pharmaceuticals's other — total revenues changed year-over-year?
Alnylam Pharmaceuticals's other — total revenues increased by 1.6% year-over-year, from $1.22M to $1.24M.
What is the long-term trend for Alnylam Pharmaceuticals's other — total revenues?
Over 2 years (2023 to 2025), Alnylam Pharmaceuticals's other — total revenues has grown at a 23.9% compound annual growth rate (CAGR), from $3.83M to $5.88M.